Broadwood Partners: Leading Proxy Advisory Firm Glass Lewis Reaffirms Recommendation “AGAINST” STAAR Surgical Sale to Alcon

Core Viewpoint - Broadwood Partners and its affiliates announced that Glass Lewis has reaffirmed its recommendation for STAAR Surgical Company shareholders to vote "AGAINST" the proposed acquisition by Alcon Inc. Glass Lewis concluded that there is no persuasive argument in favor of the acquisition [1] Group 1 - Glass Lewis is a leading independent proxy advisory firm [1] - The recommendation from Glass Lewis is based on their analysis of the proposed acquisition [1] - The report indicates a lack of compelling reasons to support the acquisition of STAAR by Alcon [1]